3

SEC Filing Details

Document Details

Form
Filing Date
Jul 11, 2019
Document Date
Jul 9, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Opiant Pharmaceuticals, Inc.
Issuer
Opiant Pharmaceuticals, Inc.